SCHEMBL1635474

SCHEMBL1635474

COc1ccc(CS)cc1SP(=O)(OC)OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.37
CA2 P00918 1/20 0.36
ALDH1A1 P00352 4/20 0.33
GAA P10253 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 2/20 0.33
LDHA P00338 1/20 0.33
FOLH1 Q04609 2/20 0.32
SIGMAR1 Q99720 1/20 0.32
PPARG P37231 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
LMNA P02545 2/20 0.32
FDPS P14324 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TTR P02766 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1636241 0.87 IDO1 (0.34) IDO1CA2ALDH1A1GAAKDM4E
SCHEMBL1634215 0.85 IDO1 (0.37) IDO1CA2ALDH1A1GAALDHA
SCHEMBL1635864 0.83 FOLH1 (0.43) KDM4EATMFOLH1HPGDSMN1; SMN2
SCHEMBL1636268 0.75 CA5A (0.39) CA2ALDH1A1GAALDHALMNA
SCHEMBL4627775 0.74 PLK1 (0.55) ALDH1A1KDM4ESMN1; SMN2TTR
SCHEMBL1636040 0.74 GAA (0.36) CA2ALDH1A1GAALDHAMAPT
SCHEMBL1634734 0.73 TTR (0.43) CA2ALDH1A1GAAKDM4ELDHA
SCHEMBL1634110 0.72 CA2 (0.46) IDO1CA2ALDH1A1KDM4EATM
SCHEMBL31208559 0.70 CA2 (0.68) IDO1CA2ALDH1A1GAAKDM4E
SCHEMBL1486320 0.70 CA2 (0.68) IDO1CA2ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
EP-1740530-B1 SUBSTITUTED PHENOXY- AND PHENYLTHIO-DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2016-09-28 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 IDO1 2676/4885CA2 4289/4885ALDH1A1 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.